Visium Secures Strategic Funding from Prominent Investors

Visium SA, based in Lausanne, Switzerland, has successfully closed its first institutional funding round. Co-led by Columbus Venture Partners and Concentric, the funding aims to boost Visium's enterprise AI operations across Europe and the US. Notably, unicorn founders participated in the funding, though the amount raised remains undisclosed.

Founded in 2018, Visium has expanded from a startup to a team of 100 AI experts, delivering over 250 AI solutions for major clients like Roche and Novartis. With this funding, Visium plans to scale its team and product capabilities for a broader reach.

Columbus Venture Partners and Concentric bring substantial expertise and hands-on investment models, aligning with Visium's ambitious growth plans. The funding is set to accelerate Visium's data-driven transformations in pharmaceuticals and biotechnology.